Oppenheimer reiterated their buy rating on shares of AMTEK (NYSE:AME) in a report published on Thursday. The firm currently has a $75.00 price target on the technology company’s stock.

A number of other brokerages have also issued reports on AME. Royal Bank of Canada restated a buy rating and set a $70.00 target price on shares of AMTEK in a research report on Friday, October 13th. Zacks Investment Research upgraded shares of AMTEK from a hold rating to a buy rating and set a $71.00 target price on the stock in a research report on Tuesday, September 5th. Morgan Stanley raised their target price on shares of AMTEK from $64.00 to $67.00 and gave the stock an equal weight rating in a research report on Friday, November 3rd. Finally, Robert W. Baird restated a buy rating and set a $70.00 target price on shares of AMTEK in a research report on Friday, October 6th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The stock has an average rating of Buy and an average price target of $73.40.

AMTEK (NYSE AME) opened at $72.60 on Thursday. The company has a market cap of $16,783.73, a P/E ratio of 30.50, a price-to-earnings-growth ratio of 2.37 and a beta of 1.36. AMTEK has a one year low of $48.21 and a one year high of $73.06. The company has a quick ratio of 1.16, a current ratio of 1.59 and a debt-to-equity ratio of 0.51.

AMTEK (NYSE:AME) last announced its quarterly earnings results on Thursday, November 2nd. The technology company reported $0.66 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.04. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.04 billion. AMTEK had a net margin of 13.37% and a return on equity of 16.48%. The firm’s revenue was up 14.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.56 earnings per share. equities research analysts anticipate that AMTEK will post 2.58 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 20th. Investors of record on Wednesday, December 6th were issued a dividend of $0.09 per share. This represents a $0.36 annualized dividend and a dividend yield of 0.50%. The ex-dividend date was Tuesday, December 5th. AMTEK’s dividend payout ratio is presently 15.13%.

In other AMTEK news, insider David A. Zapico sold 25,965 shares of the firm’s stock in a transaction on Monday, December 11th. The stock was sold at an average price of $71.77, for a total value of $1,863,508.05. Following the completion of the sale, the insider now owns 200,548 shares of the company’s stock, valued at $14,393,329.96. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Thomas M. Montgomery sold 1,800 shares of the firm’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $70.35, for a total value of $126,630.00. Following the completion of the sale, the vice president now directly owns 19,947 shares of the company’s stock, valued at approximately $1,403,271.45. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,815 shares of company stock valued at $2,408,120. Corporate insiders own 2.10% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. Commonwealth Bank of Australia raised its stake in shares of AMTEK by 17.7% during the 2nd quarter. Commonwealth Bank of Australia now owns 1,747 shares of the technology company’s stock worth $104,000 after buying an additional 263 shares during the last quarter. BB&T Investment Services Inc. acquired a new position in shares of AMTEK during the 2nd quarter worth $107,000. Zions Bancorporation acquired a new position in shares of AMTEK during the 3rd quarter worth $150,000. Edmond DE Rothschild Holding S.A. acquired a new position in shares of AMTEK during the 2nd quarter worth $151,000. Finally, Acrospire Investment Management LLC raised its stake in shares of AMTEK by 104.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,550 shares of the technology company’s stock worth $154,000 after buying an additional 1,300 shares during the last quarter. 84.24% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was originally posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another site, it was stolen and republished in violation of U.S. & international copyright legislation. The legal version of this story can be read at https://theolympiareport.com/2017/12/24/oppenheimer-reaffirms-buy-rating-for-amtek-ame.html.

AMTEK Company Profile

AMETEK, Inc is a manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. The Company operates through two segments: Electronic Instruments (EIG) and Electromechanical (EMG). EIG designs and manufactures instruments for the process, power and industrial and aerospace markets.

Analyst Recommendations for AMTEK (NYSE:AME)

Receive News & Ratings for AMTEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMTEK and related companies with MarketBeat.com's FREE daily email newsletter.